Acute-on-chronic liver failure: Pathophysiological basis of therapeutic options

被引:245
作者
Jalan, R [1 ]
Williams, R [1 ]
机构
[1] UCL, Inst Hepatol, Sch Med, London WC1E 6HX, England
关键词
liver failure; hepatic encephalopathy; hepatorenal syndrome; nitric oxide; upper gastrointestinal bleeding;
D O I
10.1159/000047017
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The vast majority of patients that are referred to a specialist hepatological Centre suffer from acute deterioration of their chronic liver disease. Yet, this entity of acute-on-chronic liver failure remains poorly defined. With the emergence of newer liver support strategies, it has become necessary to define this entity, its pathophysiology and the short- and long-term prognosis. This review focusses upon how a precipitant such as an episode of gastrointestinal bleeding or sepsis may start a cascade of events that culminate in end-organ dysfunction and liver failure. We briefly review the pathophysiological basis of the therapeutic modalities that are available. Our current strategy for the management of liver failure involves supportive therapy for the end-organs with the hope that liver function would recover if sufficient time for such a recovery is allowed. Because liver failure, whether of the acute or acute-on-chronic variety, is potentially reversible, the stage is set for the application of newer liver-support strategies to enhance the recovery process. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:252 / 261
页数:10
相关论文
共 89 条
[1]
Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide [J].
Angeli, P ;
Volpin, R ;
Gerunda, G ;
Craighero, R ;
Rone, P ;
Merenda, R ;
Amodio, P ;
Sticca, A ;
Caregaro, L ;
Maffei-Faccioli, A ;
Gatta, A .
HEPATOLOGY, 1999, 29 (06) :1690-1697
[2]
Compartmentalised inducible nitric-oxide synthase activity in septic shock [J].
Annane, D ;
Sanquer, S ;
Sébille, V ;
Faye, A ;
Djuranovic, D ;
Raphaël, JC ;
Gajdos, P ;
Bellissant, E .
LANCET, 2000, 355 (9210) :1143-1148
[3]
[Anonymous], 1979, The Hepatic Coma Syndromes and Lactulose
[4]
Ash S R, 2000, Ther Apher, V4, P218, DOI 10.1046/j.1526-0968.2000.00192.x
[5]
DOWN REGULATION OF STRIATAL DOPAMINE-RECEPTORS IN EXPERIMENTAL HEPATIC-ENCEPHALOPATHY [J].
BARALDI, M ;
ZENEROLI, ML ;
RICCI, P ;
CASELGRANDI, E ;
VENTURA, E .
LIFE SCIENCES, 1983, 32 (13) :1417-1425
[6]
Ammonia and GABA-ergic neurotransmission: Interrelated factors in the pathogenesis of hepatic encephalopathy [J].
Basile, AS ;
Jones, EA .
HEPATOLOGY, 1997, 25 (06) :1303-1305
[7]
BASILE AS, 1991, PHARMACOL REV, V43, P27
[8]
Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding:: A meta-analysis [J].
Bernard, B ;
Grangé, JD ;
Khac, EN ;
Amiot, X ;
Opolon, P ;
Poynard, T .
HEPATOLOGY, 1999, 29 (06) :1655-1661
[9]
BESSMAN AN, 1963, GASTROENTEROLOGY, V45, P368
[10]
FREQUENCY OF INFECTIONS IN CIRRHOTIC-PATIENTS PRESENTING WITH ACUTE GASTROINTESTINAL HEMORRHAGE [J].
BLEICHNER, G ;
BOULANGER, R ;
SQUARA, P ;
SOLLET, JP ;
PARENT, A .
BRITISH JOURNAL OF SURGERY, 1986, 73 (09) :724-726